Awareness for prostate cancer is especially important since the disease has no symptoms until it’s advanced. It will claim the lives of approximately 27,000 men this year. In an effort to elevate awareness, September is National Prostate Cancer Awareness Month. One in seven men will be diagnosed with prostate cancer – the most common non-skin, male-specific cancer. Nearly three million men in the US are living with a prostate cancer diagnosis; and that number is estimated to reach four million by 2024 as baby boomers age.
A fascinating new study published in Precision Oncology has found that a combination of three plant-based nutrients “melts away” prostate cancer cells. The study, led by University of Texas researcher Stefano Tiziani, is entitled Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.
As described in the University of Texas newsletter, this breakthrough discovery allows people to “starve prostate cancer with what you eat for dinner.”
CAITLIN GRANFIELD, MARCH 26, 2016
New treatments for wiping out prostate cancer are making their way into hospitals and medical centers in Miami and across the United States.
Susan Perry | 10/19/15
In 45 states (including Minnesota) and the District of Columbia, physicians are required to take continuing medical education (CME) courses to maintain their medical licenses.
Using food to prevent prostate cancer sounds too easy, doesn’t it? Research published in the Journal of the National Cancer Institute confirmed that it really can be as simple as that.
With prostate cancer rates continuing to climb, we are forced to face sexual taboos.
"Men are warned about side-effects, but clinic appointment times are not long, so doctors can't realistically talk through them all in detail," said Ali Rooke, a specialist nurse at Prostate Cancer UK. "It's also hard to predict what side-effects a man will have and how he will respond."
"We're treating these guys with normal body levels of vitamin D," lead researcher Bruce Hollis said. "We haven't even moved into the pharmacological levels yet."